Scientific Evidence

A comprehensive body of scientific evidence on natural substances developed by Aboca.

  • Real World Evidence

    Author

    Roberto Cioeta, Paola Muti, Marta Rigoni, Andrea Cossu and Emiliano Giovagnoni

    Title

    Actitan: A Natural Complex for Managing Diarrhea-Insights from Cross-Sectional Survey Research Involving Patients, Pharmacists and Physicians
    DOI https://doi.org/10.3390/gidisord6030051

    Abstract

    Diarrhea continues to be a global health problem as acute diarrhea carries the risk of dehydration, while both acute and chronic diarrhea can significantly affect patients’ quality of life and reduce productivity. The innovative medical device Actitan, which consists of a complex of natural molecules, could be an effective option for the treatment of diarrhea from various causes. The aim… Read more

    Year

    2024
    Products: Lenodiar
    Public Link
  • Real World Evidence

    Author

    R Cioeta, R Cipelli, F Panzieri, D Urbinati, V Idone, A Cossu

    Title

    Real World Clinical Data on the Use of a Natural Molecular Complex for the Treatment of Irritable Bowel Syndrome in Specialist Daily Practice
    DOI https://doi.org/10.1016/j.jval.2022.09.1880

    Abstract

    Aim of this Real World (RW) research was to investigate the effectiveness and safety of the vegetal molecular complex ActiMucin in Irritable Bowel Syndrome (IBS) patients with diarrhea predominant (IBS-D), constipation predominant (IBS-C) and mixed (IBS-M) clinical subtypes.

    Read more

    Year

    2022
    Products: Colilen IBS
    On demand
  • Real World Evidence

    Author

    Roberto Cioeta, Paola Muti, Marta Rigoni, Luigi Morlando, Filippo Siragusa, Andrea Cossu and Emiliano Giovagnoni

    Title

    Effectiveness and tolerability of Poliprotect, a natural mucosal protective agent for gastroesophageal reflux disease and dyspepsia: Surveys from patients, physicians, and pharmacists
    DOI https://doi.org/10.3389/fdsfr.2022.969831

    Abstract

    Background: Gastroesophageal reflux disease (GERD) and functional dyspepsia (FD) are very common in the general population. GERD prevalence is considerably high in pregnant women, and it increases at a young age, alongside obesity. Mucosal protective agents (MPAs) are over-the-counter (OTC) treatments for FD and GERD commonly used alone or as add-on therapy to proton pump… Read more

    Year

    2022
    Products: Neobianacid
    Public Link
  • Real World Evidence

    Author

    Roberto Cioeta, Andrea Cossu, Emiliano Giovagnoni, Marta Rigoni and Paola Muti

    Title

    A new platform for post-marketing surveillance and real-world evidence data collection for substance-based medical devices
    DOI https://doi.org/10.3389/fdsfr.2022.992359

    Abstract

    The recent passage of European Union (EU) Regulation 2017/745 on medical devices (MDs) has improved the classification of MDs and revised their approval process and the post-marketing evaluation of their safety and effectiveness, promoting transparency and post-marketing oversight in Europe. This new regulation can better ensure patient safety and provide new opportunities for therapeutic… Read more

    Year

    2022